![](/img/cover-not-exists.png)
2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis
Franken, M., Van Rooijen, E., Van Tinteren, H., May, A., Mol, L., Tije, A. Ten, Creemers, G.J., Velden, A. Van der, Van derTorren, A., Groot, C. Uyl-de, Punt, C., Koopman, M., Van Oijen, M.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31041-3
Date:
September, 2015
File:
PDF, 58 KB
english, 2015